Missteps in Current Estimates of Cancer Overdiagnosis

Christoph I. Lee, Ruth Etzioni

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The balance between the benefits and harms of imaging-based cancer screening continues to be an area of controversy and widespread media attention. Of the potential harms, overdiagnosis from screening is likely the most elusive in estimating and quantifying. This article describes the major methodological issues with recently reported estimates of overdiagnosis that are based on excess cancer incidence, and suggests that modeling focused on tumor lead-time can serve as a complementary method for excess incidence-based overdiagnosis estimates. Radiologists should be conversant on the topic of overdiagnosis and understand the limitations of different methods used to estimate its magnitude.

Original languageEnglish (US)
Pages (from-to)226-229
Number of pages4
JournalAcademic radiology
Volume24
Issue number2
DOIs
StatePublished - Feb 1 2017
Externally publishedYes

Fingerprint

Neoplasms
Incidence
Early Detection of Cancer
Medical Overuse
Radiologists

Keywords

  • cancer screening
  • mammography
  • Overdiagnosis
  • overtreatment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Missteps in Current Estimates of Cancer Overdiagnosis. / Lee, Christoph I.; Etzioni, Ruth.

In: Academic radiology, Vol. 24, No. 2, 01.02.2017, p. 226-229.

Research output: Contribution to journalReview article

Lee, Christoph I. ; Etzioni, Ruth. / Missteps in Current Estimates of Cancer Overdiagnosis. In: Academic radiology. 2017 ; Vol. 24, No. 2. pp. 226-229.
@article{506a0150b9db4cfcaa60f1bc6957d298,
title = "Missteps in Current Estimates of Cancer Overdiagnosis",
abstract = "The balance between the benefits and harms of imaging-based cancer screening continues to be an area of controversy and widespread media attention. Of the potential harms, overdiagnosis from screening is likely the most elusive in estimating and quantifying. This article describes the major methodological issues with recently reported estimates of overdiagnosis that are based on excess cancer incidence, and suggests that modeling focused on tumor lead-time can serve as a complementary method for excess incidence-based overdiagnosis estimates. Radiologists should be conversant on the topic of overdiagnosis and understand the limitations of different methods used to estimate its magnitude.",
keywords = "cancer screening, mammography, Overdiagnosis, overtreatment",
author = "Lee, {Christoph I.} and Ruth Etzioni",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.acra.2016.05.020",
language = "English (US)",
volume = "24",
pages = "226--229",
journal = "Academic Radiology",
issn = "1076-6332",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Missteps in Current Estimates of Cancer Overdiagnosis

AU - Lee, Christoph I.

AU - Etzioni, Ruth

PY - 2017/2/1

Y1 - 2017/2/1

N2 - The balance between the benefits and harms of imaging-based cancer screening continues to be an area of controversy and widespread media attention. Of the potential harms, overdiagnosis from screening is likely the most elusive in estimating and quantifying. This article describes the major methodological issues with recently reported estimates of overdiagnosis that are based on excess cancer incidence, and suggests that modeling focused on tumor lead-time can serve as a complementary method for excess incidence-based overdiagnosis estimates. Radiologists should be conversant on the topic of overdiagnosis and understand the limitations of different methods used to estimate its magnitude.

AB - The balance between the benefits and harms of imaging-based cancer screening continues to be an area of controversy and widespread media attention. Of the potential harms, overdiagnosis from screening is likely the most elusive in estimating and quantifying. This article describes the major methodological issues with recently reported estimates of overdiagnosis that are based on excess cancer incidence, and suggests that modeling focused on tumor lead-time can serve as a complementary method for excess incidence-based overdiagnosis estimates. Radiologists should be conversant on the topic of overdiagnosis and understand the limitations of different methods used to estimate its magnitude.

KW - cancer screening

KW - mammography

KW - Overdiagnosis

KW - overtreatment

UR - http://www.scopus.com/inward/record.url?scp=85007093236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007093236&partnerID=8YFLogxK

U2 - 10.1016/j.acra.2016.05.020

DO - 10.1016/j.acra.2016.05.020

M3 - Review article

C2 - 27894707

AN - SCOPUS:85007093236

VL - 24

SP - 226

EP - 229

JO - Academic Radiology

JF - Academic Radiology

SN - 1076-6332

IS - 2

ER -